Skip to main content
. 2019 Jan 15;69(679):e80–e87. doi: 10.3399/bjgp19X700769

Table 2.

Distribution and odds ratios (ORs) for the GP to suspect cancer according to the patient’s usual GP consultation frequencya

GP-suspected cancer

Observed Crude Adjustedb



Usual GP consultation frequencya n % OR (95% CI) Trendc OR (95% CI) Trendc
Overall
Rare (n = 748) 361 48.3 1.09 0.92 to 1.30 1.14 0.95 to 1.37
Average (n = 2219) 1031 46.5 1.00 ref 1.00 ref
Frequent (n = 1018) 434 42.6 0.83 0.71 to 0.96 P= 0.018 0.78 0.66 to 0.91 P<0.001

Females
Rare (n = 303) 158 52.1 1.02 0.79 to 1.32 1.03 0.77 to 1.39
Average (n = 1036) 536 51.7 1.00 ref 1.00 ref
Frequent (n = 534) 245 45.9 0.77 0.63 to 0.96 P= 0.059 0.72 0.57 to 0.91 P= 0.032

Males
Rare (n = 445) 203 45.6 1.16 0.93 to 1.44 1.19 0.95 to 1.50
Average (n = 1183) 495 41.8 1.00 ref 1.00 ref
Frequent (n = 484) 189 39.0 0.88 0.71 to 1.10 P= 0.044 0.83 0.66 to 1.04 P= 0.011

Age 18–44 years
Rare (n = 63) 26 41.3 0.80 0.44 to 1.45 0.86 0.46 to 1.62
Average (n = 192) 89 46.4 1.00 ref 1.00 ref
Frequent (n = 44) 15 34.1 0.61 0.31 to 1.19 P= 0.522 0.56 0.27 to 1.16 P= 0.334

Age 45–54 years
Rare (n = 121) 56 46.3 0.81 0.52 to 1.25 0.90 0.55 to 1.46
Average (n = 295) 149 50.5 1.00 ref 1.00 ref
Frequent (n = 69) 26 37.7 0.56 0.33 to 0.95 P= 0.233 0.55 0.27 to 1.16 P= 0.144

Age 55–64 years
Rare (n = 227) 102 44.9 1.12 0.82 to 1.53 1.20 0.87 to 1.65
Average (n = 525) 218 41.5 1.00 ref 1.00 ref
Frequent (n = 166) 68 41.0 0.96 0.66 to 1.40 P= 0.474 0.82 0.55 to 1.23 P= 0.104

Age 65–74 years
Rare (n = 229) 116 50.7 1.34 0.98 to 1.82 1.39 1.00 to 1.93
Average (n = 640) 278 43.4 1.00 ref 1.00 ref
Frequent (n = 334) 144 43.1 1.00 0.76 to 1.31 P= 0.091 0.97 0.73 to 1.29 P= 0.057

Age 75–84 years
Rare (n = 87) 50 57.5 1.33 0.82 to 2.16 1.39 0.83 to 2.34
Average (n = 454) 231 50.9 1.00 ref 1.00 ref
Frequent (n = 301) 129 42.9 0.72 0.54 to 0.96 P<0.05 0.69 0.50 to 0.94 P<0.05

Age85 years
Rare (n = 21) 11 52.4 0.78 0.31 to 1.96 0.49 0.18 to 1.32
Average (n = 113) 66 58.4 1.00 ref 1.00 ref
Frequent (n = 104) 52 50.0 0.71 0.41 to 1.24 P= 0.841 0.63 0.34 to 1.18 P= 0.618

No comorbidity
Rare (n = 665) 318 47.8 1.07 0.89 to 1.28 1.15 0.95 to 1.40
Average (n = 1803) 830 46.0 1.00 ref 1.00 ref
Frequent (n = 654) 283 43.3 0.89 0.74 to 1.07 P= 0.101 0.79 0.65 to 0.96 P<0.01

Moderate comorbidity
Rare (n = 72) 37 51.4 1.09 0.67 to 1.80 1.31 0.75 to 2.27
Average (n = 361) 173 47.9 1.00 ref 1.00 ref
Frequent (n = 292) 123 42.1 0.79 0.58 to 1.08 P= 0.213 0.80 0.58 to 1.11 P= 0.093

High comorbidity
Rare (n = 11) 6 54.5 1.07 0.23 to 4.04 2.34 0.24 to 22.98
Average (n = 55) 28 50.9 1.00 ref 1.00 ref
Frequent (n = 72) 28 38.9 0.57 0.28 to 1.17 P= 0.342 0.49 0.21 to 1.17 P= 0.168
a

Usual consultation frequency defined according to the patient’s number of face-to-face contacts in the 19–36 months before the cancer diagnosis.

b

Adjusted for sex, age group, diagnosis, comorbidity, disposable household income, and educational level. Estimates marked by bold were statistically significant at P0.05.

c

Test for linear trend across categories. ref = reference